Skip to content

Thursday, July 3, 2025

Latest:

Surviving cancer and tracheoesophageal fistula: Sandy Tovey’s journey
Handy ‘MasSpec Pen’ collection could help detect opioids from the skin
A culturally sensitive approach for pediatricians to navigate co-sleeping conversations with families
Baylor recognizes faculty excellence in research with DeBakey Awards
What you need to know about sickle cell disease

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

Spliceosome-targeting therapies

Study of spliceosome-targeting cancer therapies reveals an overlooked role of mis-spliced RNAs themselves

January 19, 2021 apoptosis, cancer treatment, Immunotherapy, Research, RNA splicing, Spliceosome-targeting therapies, triple-negative breast cancer

Endogenous mis-spliced RNA in tumor cells mimics an RNA virus, leading tumor cells to self-destruct as if fighting an infection.

From the Labs: Image of the Month

From the Labs: a closer look at metastatic medulloblastoma

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951